105105-00-8,
4-(2,3-dihydroindol-1-yl)-4-oxo-butyric acid,
4-(2,3-Dihydro-indol-1-yl)-4-oxo-butyric acid,
4-(2,3-dihydro-1H-indol-1-yl)-4-oxobutanoic acid,
4-(Indolin-1-yl)-4-oxobutanoic acid,
CHEMBL357516,
4-indolinyl-4-oxobutanoic acid,
BAS 00877534,
TimTec1_002922,
Oprea1_163756,
Oprea1_411587,
CBDivE_000645,
AC1LE559,
ARONIS019368,
SCHEMBL2278917,
1-(3-carboxypropionyl) indoline,
CTK7J2742,
gamma-Oxoindoline-1-butyric acid,
BBB/345,
DTXSID10352628,
SWNRXQYQTQVWKA-UHFFFAOYSA-N,
HMS1542E18,
ZINC143134,
KS-00004BC8,
ZX-AS003580,
8139AC,
BBL009138,
BDBM50136875,
MFCD00458379,
SBB000588,
STK099228,
AKOS000141204,
CCG-200863,
MCULE-8578773876,
RTR-040302,
ST040410,
BB0274306,
TR-040302,
EU-0066097,
H3286,
4-(2,3-dihydroindol-1-yl)-4-oxobutanoic acid,
SR-01000394484,
SR-01000394484-1,
4-(2,3-Dihydro-1H-indol-1-yl)-4-oxobutanoic acid, AldrichCPR,
C12H13NO3,
CID730429,